Aimen Waqar Khan

Aimen Waqar Khan

Auto-generated profile, based on publicly available information

Aimen Waqar Khan

Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2024 in Health Science Reports
Verified
Journal Article
Open access
MOMalik Olatunde Oduoye
Malik Olatunde Oduoye
MMMohammed Dheyaa Marsool Marsool
Mohammed Dheyaa Marsool Marsool
MHMuhammad Usman Haider
Muhammad Usman Haider
DMDattatreya Mukherjee
Dattatreya Mukherjee
AKAimen Waqar Khan
Aimen Waqar Khan
TDTirth Dave
Tirth Dave
Background and aims: The World Health Organization has recently declared the frequent outbreaks of diphtheria in Nigeria as a public health concern. Although vaccination efforts have been successful in Nigeria, unfortunately, the recent 2023 outbreak in Nigeria has been nothing short of distressing. Of course, cases of diphtheria incidence are under‐reported in Nigeria. This present article aims to proffer a possible multifaceted approach to tackle outbreaks of diphtheria in Nigeria and improve immunization rates against the disease among the Nigerian populationMethods: In writing this study, literature search was done about diphtheria in Nigeria using the following keywords: “diphtheria, prevalence, vaccination, efforts, challenges, and Nigeria” on PubMed, Web of Science, Google Scholar, and ResearchGate within 10 years.Result: This study found that an estimated seven million people remain unvaccinated and are at risk for infection in the country, especially people living in the Northern part of the country. Between the June 30 and August 31, 2023, Nigeria recorded an unusual increase in the number of confirmed cases of diphtheria, where a total of 5898 suspected cases were reported from 59 local government areas in 11 states across Nigeria. The majority (99.4%) of suspected cases of the disease were reported from six states: Kano (1816), Katsina (234), Yobe (158), Bauchi (79), Kaduna (45), and Borno (33).Conclusion: If Nigeria is to emerge beyond these frequent epidemics of diphtheria, the Nigerian government must work on tackling this issue on multiple fronts simultaneously, that is, at the national and international levels, as we believe that these levels would give a holistic way to unmask diphtheria in Nigeria.

7 October 2024 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
SASyeda Dua Azhar
Syeda Dua Azhar
NSNayab Shahid
Nayab Shahid
ASAiman Sadiq
Aiman Sadiq
AKAimen Waqar Khan
Aimen Waqar Khan
MDMarrium Sultan Dar
Marrium Sultan Dar
TATagwa Kalool Fadlalla Ahmed
Tagwa Kalool Fadlalla Ahmed
An abstract is unavailable. This article is available as a PDF only.

10 January 2025 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
DGDua Gul
Dua Gul
AKAimen Waqar Khan
Aimen Waqar Khan
MBMuhammad Abdurrahman Butt
Muhammad Abdurrahman Butt
MSMahammed Khan Suheb
Mahammed Khan Suheb
SSSahil Sartaj
Sahil Sartaj
SKSatesh Kumar
Satesh Kumar

16 June 2023 in International Journal of Surgery: Global Health
Verified
Journal Article
Open access
AKAimen Waqar Mbbs Khan
Aimen Waqar Mbbs Khan
TNTooba Mbbs Noor
Tooba Mbbs Noor
UMUsama Abdul Ahad Mbbs Memon
Usama Abdul Ahad Mbbs Memon
ASAreej Mbbs Shakil
Areej Mbbs Shakil

25 January 2024 in Health Science Reports
Verified
Journal Article
Open access
MDMarrium Sultan Dar
Marrium Sultan Dar
NSNayab Shahid
Nayab Shahid
AWArisha Waqas
Arisha Waqas
YBYumna Arif Baig
Yumna Arif Baig
AKAimen Waqar Khan
Aimen Waqar Khan
Background and Aims: Pediatric‐type low‐grade gliomas (pLGGs) are the most common solid tumors in children, with v‐raf murine sarcoma viral oncogene homolog B (BRAF) mutations playing a significant role in their development. Dabrafenib and trametinib are targeted therapies that are recently approved by Food and Drug Administration for pediatric patients with pLGG harboring a BRAF V600E mutation.Body: This study emphasizes the role of Dabrafenib and Trametinib in pLGG. A multicenter Phase I/II trial demonstrated the superior efficacy of dabrafenib plus trametinib (D+T) compared to carboplatin plus vincristine (C+T), with higher overall response rates, clinical benefit rates, and longer progression‐free survival. The safety profile of dabrafenib plus trametinib (D+T) was favorable, with fewer discontinuations and adverse events compared to the control group.Conclusion: The introduction of D+T as a targeted therapy represents a significant advancement in the management of pLGG, necessitating further investigations to understand its long‐term consequences and optimize patient care.

30 October 2024 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
AKAimen Waqar Khan
Aimen Waqar Khan
MDMarrium Sultan Dar
Marrium Sultan Dar
RNRayyan Nabi
Rayyan Nabi
AAAhmad Ali
Ahmad Ali
MHMuhammad Abdullah Humayun
Muhammad Abdullah Humayun
EREman Riaz
Eman Riaz
Racial and ethnic disparities have long been studied in the delivery of healthcare. One such avenue is acute pediatric appendicitis, which continues to be an area of significant and continual research. Because of its routine clinical presentation and standardized management, acute pediatric appendicitis serves as an appropriate proxy for studying discrepancies in healthcare. Our review therefore aims to comprehensively highlight the various dimensions of its clinical management subject to disparities, their collective clinical impact, and future recommendations to mitigate it.